DUBLIN--(BUSINESS WIRE)--Research and Markets has announced the addition of the "Human Biobanking Technologies - Global Trends, Estimates and Forecasts, 2014-2020" report to their offering.
Human Biobanking Technologies - Global Trends, Estimates and Forecasts, 2014-2020 reviews the latest human biobanking market trends with a perceptive attempt to disclose the near-future growth prospects.
Globally, Radio Frequency Identification & Tagging and Dry-State Storing together account for approximately 55% of the market share expected to support the Human Biobanking Technologies industry.
Geographical analysis shows that the highest Compounded Annual Growth Rate (CAGR) of 10.14% is anticipated from Asia-Pacific region during the analysis period 2014-2020. North America and Europe together account for more than 50% of the global market share by end of 2020 respectively.
An in-depth analysis on a geographic basis provides strategic business intelligence for life science sector investments. The study reveals profitable investment strategies for pharmaceutical manufacturers, biotechnology companies, laboratories, Contract Research Organizations (CROs) and many more in preferred locations.
The report primarily focuses on:
- Emerging market trends
- Advancements in the technological space
- Market demand of the segments (by-region)
- Key growth areas and market size
- Key competitor's Edge
Further, the subdivided categories include:
1.Radio Frequency Identification (RFID) & Tagging
2.Automated Liquid Handling
- a.Vitrification/Ultra-Fast Cooling Techniques
- b.Low Cryo Protectant Techniques
- c.Single-Nucleotide Polymorphism (SNP)
More than 1250 leading market players are identified and 107 key companies that project improved market activities in the near future are profiled. The report consists of 72 data charts describing the market shares, sales forecasts and growth prospects. Moreover, key strategic activities in the market including mergers/acquisitions, collaborations/partnerships, product launches/developments are discussed.
Key Topics Covered:
I. Report Focus
B. Biobanking Benefits
C. Biospecimens (Collection, Processing, Storage, Retrieval And Disseminate)
D. Biobanking Principles
E. Path Breaking Technologies
F. Biobanking Performances
G. Biobank Technologies
H. Human Biobanking Technologies - Geography Market Briefing
II. Market Analysis
A. Human Biobanking Technologies - Segmentation
B. Growth Rate Analysis
C. Investment Focus
III. Industry Overview
A. Biobanking - Geographical Distribution In Detail
B. A Review On Bio Banks
C. Major Prospects For Biorepositories In The Future
D. Industry Activities
E. Market Trends
F. Key Company Profiles - 35 of the 100+ Companies Featured
- Abbott Laboratories
- Acorda Therapeutics, Inc.
- Affymetrix, Inc.
- Alpha Cord, Inc.
- Cellerant Therapeutics, Inc.
- Cells4Life, Ltd.
- Cesca Therapeutics, Inc.
- Epistem Ltd.
- Epl Archieves, Inc.
- Eppendorf, Inc.
- Gamida Cell Ltd.
- Ge Healthcare Life Sciences
- Genzyme Corp.
- Gilead Sciences, Inc.
- Lifelines Cohort And Biobank (Lifelines)
- Lifeline® Cell Technology
- Lifenet Health
- Linde Gas Cryoservices B.V.
- Mesoblast, Inc.
- Modul-Bio Sas
- Mts Cryostores Uk Ltd
- Noray Bioinformatics S.L.U.
- Novare Biologistics
- Ocimum Biosolutions
- Origen Biomedical, Inc.
- Osiris Therapeutics, Inc.
- Pacific Bio-Material Management, Inc.
- Panasonic Biomedical Sales Europe B.V
- Sanofi Aventis
- Steelgate, Inc.
- Stem Cells, Inc.
- Wheaton Science Products, Inc.
For more information visit http://www.researchandmarkets.com/research/m6t6vg/human_biobanking